Literature DB >> 11893103

Primary hyperaldosteronism in the era of laparoscopic adrenalectomy.

Heather Rossi1, Anthony Kim, Richard A Prinz.   

Abstract

Laparoscopic adrenalectomy has been recommended as the standard method for removing an aldosteronoma. To assess our surgical experience with primary hyperaldosteronism in the era of laparoscopic adrenalectomy a 6-year retrospective review of 30 consecutive patients was done. The 20 men and 10 women ranged in age from 35 to 78 with a mean of 51.2 years. All patients were hypertensive and hypokalemic with a mean serum potassium of 2.9 +/- 0.32 (standard deviation) mmol/L. Serum aldosterone was elevated in 28 of 30 (94%) patients and normal in the remaining two. Serum renin was suppressed in all patients. CT correctly localized the tumor in all 30 patients. Twenty-eight patients had histologically documented adenomas and two had associated cortical hyperplasia on pathology. Mean adenoma size was 2.0 +/- 1.12 cm. Twenty-four patients underwent left laparoscopic adrenalectomies, whereas right laparoscopic adrenalectomies were performed in five. One was converted to an open left adrenalectomy. Mean operative time was 183 minutes. The mean hospital stay for laparoscopic adrenalectomy was 2.2 days. The patients were followed from one to 63 months (mean 26.1 months). Twenty-nine of 30 (95%) patients were rendered normokalemic. The remaining patient takes a potassium-wasting diuretic. Persistent hypertension was present in 10 of 30 (33%) patients. Blood pressure in nine of 10 patients was controlled with less medical therapy. The other patient's blood pressure remained difficult to control despite multiple medications. Duration of hypertension before surgery was a significant risk factor for persistent hypertension (P < 0.05). Gender (P > 0.05) and age (P > 0.05) at the time of surgery were not statistically significant predicators for persistent hypertension. There were two reported trocar site hernias. We conclude that primary hyperaldosteronism due to aldosterone-producing tumors can be diagnosed and accurately localized with preoperative measurements of serum aldosterone, renin, and CT scanning. Laparoscopic adrenalectomy is safe and effective for the treatment of primary hyperaldosteronism with minimal associated morbidity and a short hospital stay. Hypokalemia may be cured by surgical treatment, although persistent hypertension still occurs. Duration of hypertension before surgery is a risk factor for persistent hypertension whereas age and sex are not.

Entities:  

Mesh:

Year:  2002        PMID: 11893103

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  18 in total

1.  Laparoscopic adrenalectomy for Conn's syndrome complicated by ipsilateral congenital pelvic kidney.

Authors:  Z D Vaughn; F E Johnson; R I Beretvas
Journal:  Surg Endosc       Date:  2004-08-24       Impact factor: 4.584

2.  Retroperitoneoscopic adrenalectomy in Conn's syndrome caused by adrenal adenomas or nodular hyperplasia.

Authors:  Martin K Walz; Roland Gwosdz; Stephanie L Levin; Piero F Alesina; Anna-Carinna Suttorp; Klaus A Metz; Frank A Wenger; Stephan Petersenn; Klaus Mann; Kurt W Schmid
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

3.  Outcome of surgery for primary hyperaldosteronism.

Authors:  Jens Waldmann; Lisa Maurer; Julia Holler; Peter H Kann; Annette Ramaswamy; Detlef K Bartsch; Peter Langer
Journal:  World J Surg       Date:  2011-11       Impact factor: 3.352

4.  Selective use of adrenal venous sampling in the lateralization of aldosterone-producing adenomas.

Authors:  Yah Yuen Tan; Jennifer B Ogilvie; Frederick Triponez; Nadine R Caron; Electron K Kebebew; Orlo H Clark; Quan-Yang Duh
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

Review 5.  Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension.

Authors:  Satoshi Morimoto; Atsuhiro Ichihara
Journal:  Hypertens Res       Date:  2020-05-18       Impact factor: 3.872

Review 6.  Primary Aldosteronism: Cardiovascular Outcomes Pre- and Post-treatment.

Authors:  Gregory L Hundemer
Journal:  Curr Cardiol Rep       Date:  2019-07-27       Impact factor: 2.931

Review 7.  Primary aldosteronism: from bench to bedside.

Authors:  Norlela Sukor
Journal:  Endocrine       Date:  2011-11-01       Impact factor: 3.633

Review 8.  Treatment of primary aldosteronism: Where are we now?

Authors:  Asterios Karagiannis
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

Review 9.  Surgical approach to patients with primary aldosteronism.

Authors:  Catherine McManus; Jennifer H Kuo
Journal:  Gland Surg       Date:  2020-02

10.  Long-term results of laparoscopic adrenalectomy for primary aldosteronism.

Authors:  R Campagnacci; F Crosta; A De Sanctis; M Baldarelli; G Giacchetti; A M Paganini; M Coletta; M Guerrieri
Journal:  J Endocrinol Invest       Date:  2009-01       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.